CO₂ Inhalation Clears Alzheimer’s Proteins in Brain
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Sephira Ryman and colleagues at the University of Texas at Austin tested intermittent 5% CO₂ inhalation for 30 minutes, triggering brain blood vessel pulsations that mimic deep sleep and activate the glymphatic system.
- The 12-person trial showed increased blood levels of beta-amyloid 15 minutes post-exposure, suggesting enhanced clearance of Alzheimer’s-related proteins from the brain.
- Clearance of tau protein improved after CO₂ exposure, but only in participants with elevated baseline tau or mild cognitive impairment, possibly due to higher initial accumulation.
- Vincent Tay notes the amyloid and tau clearance effects returned to baseline within about an hour, underscoring the need for long-term studies on dosing frequency and disease modification.
- Jeff Iliff highlights that glymphatic stimulation isn’t specific to Alzheimer’s, potentially aiding clearance of alpha-synuclein in Parkinson’s and other neurodegenerative waste proteins.
- Ryman suggests future use of a portable CO₂ delivery device at home could offer a non-pharmacological alternative to drugs currently used to enhance brain waste clearance.
Why it matters: This approach could shift how neurodegenerative diseases are treated if repeated sessions prove to slow cognitive decline, offering a low-cost, drug-free intervention that targets multiple harmful proteins—but without evidence yet that short-term clearance translates to long-term protection, the clinical benefit remains uncertain.
